\-\ Texto\\:\\ \ \(0\)\
\-\ na\ \(21935\)\
\-\ na\ \(21935\)\
\-\ ap\\ radiographs\\ of\\ the\\ left\\ hip\\ show\\ a\\ geographic\\ lesion\\ with\\ a\\ thin\\,\\ well\\-defined\\ sclerotic\\ margin\\ in\\ the\\ intertrochanteric\\ region\\ of\\ the\\ femur\\.\\ there\\ is\\ globular\\ amorphous\\ mineralized\\ matrix\\ in\\ the\\ middle\\ lower\\ portion\\ of\\ the\\ lesion\\,\\ with\\ more\\ extensively\\ mineralized\\ globular\\ matrix\\ in\\ the\\ upper\\ aspect\\.\ \(0\)\
\-\ axial\\ ct\\ scan\\ through\\ the\\ middle\\ portion\\ of\\ the\\ lesion\\ shows\\ the\\ mineralized\\ matrix\\.\\ the\\ attenuation\\ of\\ the\\ lesion\\ is\\ greater\\ than\\ that\\ of\\ marrow\\ fat\\ and\\ less\\ than\\ that\\ of\\ skeletal\\ muscle\\.\ \(0\)\
\-\ liposclerosing\\ myxofibrous\\ tumor\\ of\\ bone\\ \\(lsmft\\)\ \(0\)\
\-\ 1\\.\\ fibrous\\ dysplasia\ \(0\)\
\-\ 2\\.\\ fibroxanthoma\\ \ \(0\)\
\-\ 3\\.\\ myxofibroma\ \(0\)\
\-\ 4\\.\\ lipoma\ \(0\)\
\-\ 5\\.\\ cyst\ \(0\)\
\-\ 6\\.\\ bone\\ infarct\ \(0\)\
\-\ 7\\.\\ paget\\'s\\ disease\ \(0\)\
\-\ 8\\.\\ chondroma\ \(0\)\
\-\ 40\\ y\\/o\\ male\\ with\\ hip\\ pain\\.\ \(1\)\
\-\ lsmft\\ has\\ a\\ predilection\\ for\\ the\\ proximal\\ femur\\ at\\ the\\ intertrochanteric\\ region\\ \\-\\ as\\ was\\ seen\\ in\\ this\\ case\\.\\ \\ more\\ than\\ 90\\%\\ of\\ these\\ femoral\\ lesions\\ occur\\ here\\.\ \(0\)\
\-\ radiographs\\ showed\\ a\\ well\\-defined\\,\\ sclerotic\\ margin\\.\\ the\\ bone\\ contour\\ showed\\ mild\\ expansile\\ remodeling\\.\\ mineralization\\ within\\ the\\ lesion\\ was\\ apparent\\.\\ \\ findings\\ at\\ computed\\ tomography\\ reflected\\ those\\ at\\ radiography\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ mineralized\\:\\ 0\\.3239015962918317\ \(0\)\
\-\ lsmft\\:\\ 0\\.2505379266012405\ \(0\)\
\-\ matrix\\:\\ 0\\.24738041359828894\ \(0\)\
\-\ the\\:\\ 0\\.24535446805285657\ \(0\)\
\-\ globular\\:\\ 0\\.21896257694659998\ \(0\)\
\-\ intertrochanteric\\:\\ 0\\.2106942714481706\ \(0\)\
\-\ lesion\\:\\ 0\\.19650297308136283\ \(0\)\
\-\ na\\:\\ 0\\.15545922141102542\ \(0\)\
\-\ of\\:\\ 0\\.1443791404211727\ \(0\)\
\-\ margin\\:\\ 0\\.1438056993329198\ \(0\)\
\-\ than\\:\\ 0\\.13940773457769312\ \(0\)\
\-\ sclerotic\\:\\ 0\\.137532846997717\ \(0\)\
\-\ femur\\:\\ 0\\.1345046675790048\ \(0\)\
\-\ bone\\:\\ 0\\.13418419486350477\ \(0\)\
\-\ hip\\:\\ 0\\.12594201005209404\ \(0\)\
\-\ myxofibroma\\:\\ 0\\.12526896330062026\ \(0\)\
\-\ liposclerosing\\:\\ 0\\.12113481055140557\ \(0\)\
\-\ myxofibrous\\:\\ 0\\.12113481055140557\ \(0\)\
\-\ reflected\\:\\ 0\\.12113481055140557\ \(0\)\
\-\ middle\\:\\ 0\\.11723775285205475\ \(0\)\
\-\ portion\\:\\ 0\\.11723775285205475\ \(0\)\
\-\ fibroxanthoma\\:\\ 0\\.11530804951235278\ \(0\)\
\-\ extensively\\:\\ 0\\.10948128847329999\ \(0\)\
\-\ showed\\:\\ 0\\.10920217025956705\ \(0\)\
\-\ radiographs\\:\\ 0\\.1063356754552328\ \(0\)\
\-\ amorphous\\:\\ 0\\.09874339838771952\ \(0\)\
\-\ region\\:\\ 0\\.09806736995680343\ \(0\)\
\-\ geographic\\:\\ 0\\.0980062849756764\ \(0\)\
\-\ chondroma\\:\\ 0\\.0980062849756764\ \(0\)\
\-\ predilection\\:\\ 0\\.09479958697648219\ \(0\)\
\-\ at\\:\\ 0\\.09288888190476241\ \(0\)\
\-\ remodeling\\:\\ 0\\.09125206918660313\ \(0\)\
\-\ more\\:\\ 0\\.09002598494533288\ \(0\)\
\-\ mineralization\\:\\ 0\\.08840920228953603\ \(0\)\
\-\ radiography\\:\\ 0\\.08373269985771224\ \(0\)\
\-\ in\\:\\ 0\\.08157078703449595\ \(0\)\
\-\ paget\\:\\ 0\\.08129115539833565\ \(0\)\
\-\ tomography\\:\\ 0\\.07940032933243589\ \(0\)\
\-\ computed\\:\\ 0\\.07901191214916192\ \(0\)\
\-\ here\\:\\ 0\\.07808445739914144\ \(0\)\
\-\ skeletal\\:\\ 0\\.07431413575205385\ \(0\)\
\-\ expansile\\:\\ 0\\.07417661737320692\ \(0\)\
\-\ contour\\:\\ 0\\.07377178606944476\ \(0\)\
\-\ that\\:\\ 0\\.07114807201935773\ \(0\)\
\-\ lipoma\\:\\ 0\\.07110743775285966\ \(0\)\
\-\ those\\:\\ 0\\.07014547983878525\ \(0\)\
\-\ apparent\\:\\ 0\\.06857979021429486\ \(0\)\
\-\ infarct\\:\\ 0\\.06821364146666234\ \(0\)\
\-\ marrow\\:\\ 0\\.06812354361087396\ \(0\)\
\-\ 90\\:\\ 0\\.06550348057101536\ \(0\)\
\-\ thin\\:\\ 0\\.06381087228117728\ \(0\)\
\-\ fibrous\\:\\ 0\\.06367842377746673\ \(0\)\
\-\ dysplasia\\:\\ 0\\.06278396688563048\ \(0\)\
\-\ attenuation\\:\\ 0\\.06272215792615163\ \(0\)\
\-\ femoral\\:\\ 0\\.06092712182616507\ \(0\)\
\-\ greater\\:\\ 0\\.0603928386949466\ \(0\)\
\-\ 40\\:\\ 0\\.06028832506391478\ \(0\)\
\-\ occur\\:\\ 0\\.06028832506391478\ \(0\)\
\-\ ap\\:\\ 0\\.058852549231888436\ \(0\)\
\-\ muscle\\:\\ 0\\.05820760814078019\ \(0\)\
\-\ was\\:\\ 0\\.0571381342550084\ \(0\)\
\-\ less\\:\\ 0\\.05576887950602807\ \(0\)\
\-\ aspect\\:\\ 0\\.05288512905101587\ \(0\)\
\-\ show\\:\\ 0\\.052039558060575544\ \(0\)\
\-\ proximal\\:\\ 0\\.051213272477310987\ \(0\)\
\-\ fat\\:\\ 0\\.05099345081558254\ \(0\)\
\-\ through\\:\\ 0\\.048797709874451554\ \(0\)\
\-\ scan\\:\\ 0\\.048634802985809196\ \(0\)\
\-\ with\\:\\ 0\\.0481551356410569\ \(0\)\
\-\ shows\\:\\ 0\\.04811217953955089\ \(0\)\
\-\ axial\\:\\ 0\\.047351654945150985\ \(0\)\
\-\ cyst\\:\\ 0\\.047288301892103805\ \(0\)\
\-\ lesions\\:\\ 0\\.047079119728096294\ \(0\)\
\-\ mild\\:\\ 0\\.04646924485923104\ \(0\)\
\-\ these\\:\\ 0\\.04629121773959706\ \(0\)\
\-\ is\\:\\ 0\\.04489877114475088\ \(0\)\
\-\ upper\\:\\ 0\\.04380612144555538\ \(0\)\
\-\ tumor\\:\\ 0\\.04287763317682289\ \(0\)\
\-\ lower\\:\\ 0\\.041889267692877284\ \(0\)\
\-\ case\\:\\ 0\\.04118330252095827\ \(0\)\
\-\ findings\\:\\ 0\\.040457905270786375\ \(0\)\
\-\ seen\\:\\ 0\\.03859312308652995\ \(0\)\
\-\ within\\:\\ 0\\.03775511494366259\ \(0\)\
\-\ has\\:\\ 0\\.03744374955680716\ \(0\)\
\-\ male\\:\\ 0\\.036498382603328404\ \(0\)\
\-\ disease\\:\\ 0\\.03441015431760396\ \(0\)\
\-\ as\\:\\ 0\\.0329322299792949\ \(0\)\
\-\ there\\:\\ 0\\.032617561600501076\ \(0\)\
\-\ ct\\:\\ 0\\.03120861723098993\ \(0\)\
\-\ pain\\:\\ 0\\.029333638969213097\ \(0\)\
\-\ this\\:\\ 0\\.028168054734454138\ \(0\)\
\-\ left\\:\\ 0\\.027963429089606157\ \(0\)\
\-\ for\\:\\ 0\\.024845965570471164\ \(0\)\
\-\ and\\:\\ 0\\.016939111182291036\ \(0\)\
